Target Audience (click to view)
This activity is designed to meet the needs of physicians.
Learning Objectives(click to view)
Upon completion of the educational activity, participants should be able to:
- Discuss the outcomes of an emergency department-based screening program for hepatitis C that was implemented into the triage process according to recommendations from the CDC and United States Preventive Services Task Force.
Method of Participation(click to view)
Statements of credit will be awarded based on the participant reviewing monograph, correctly answer 2 out of 3 questions on the post test, completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.akhcme.com/pwOct02. You must participate in the entire activity to receive credit. If you have questions about this CME/CE activity, please contact AKH Inc. at email@example.com.
Credit Available(click to view)
CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly’s. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support(click to view)
There is no commercial support for this activity.
Disclosures(click to view)
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use & Investigational Product(click to view)
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer(click to view)
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
Faculty & Credentials(click to view)
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
Dorothy Caputo, MA, BSN, RN- CE Director of Accreditation
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH planners and reviewers have no relevant financial relationships to disclose.
Complete the Post Test(click to view)
An ED screening and diagnostic testing program found a high prevalence of hepatitis C. Results suggest that continued efforts are needed to develop and evaluate policies for ED-based hepatitis C screening.
Hepatitis C virus affects about 3 million Americans and is a leading cause of end-stage liver disease, hepatocellular carcinoma, and liver transplants. National recommendations endorse using risk-based hepatitis C screening, which includes screening patients with a history of injection drug use as well as one-time screenings of “baby boomers,” or patients born between 1945 and 1965. Current data suggest that the baby boomer generation accounts for 75% of people infected with hepatitis C, but 1.25 to 1.75 million of them are unaware that they are infected.
“Hepatitis C screening has long been considered impractical for EDs, but advances in rapid testing technology, the development of new therapies, and improvements in reimbursement for selective screening has created new opportunities to implement these screenings in the ED setting,” says Douglas A.E. White, MD. Despite these advances, clinical experience with hepatitis C virus screening in EDs is limited.
Testing a New Program
Recently, Dr. White and colleagues at Alameda Health System implemented an ED-based screening program for both HIV and hepatitis C into the triage process according to recommendations from the CDC and United States Preventive Services Task Force. As an adjunct to screening, physicians could order HIV and hepatitis C testing when clinically indicated. For a study published in Annals of Emergency Medicine, the research team reported results of the hepatitis C portion of this screening program. The primary objective was to determine the prevalence of hepatitis C among tested patients, but the authors also evaluated factors associated with testing positive.
Of the more than 26,000 unique adults who presented to the ED during the study period, almost 10% completed hepatitis C screening or diagnostic testing. “Among these individuals, 10% were antibody positive,” says Dr. White. Several factors were associated with testing positive for hepatitis C, including using injection drugs, being homeless, and receiving diagnostic testing, among others (Table). For those testing positive for the hepatitis C antibody, more than half had documentation of their results being disclosed and two-thirds had confirmatory ribonucleic acid testing performed, of whom 70% had a positive result. Follow-up appointments at the hepatitis C virus clinic were arranged for 45% patients with confirmed positive results.
“During our integrated ED screening program, the prevalence of testing positive for hepatitis C was high across all patient groups that were screened, including those outside of the CDC-recommended risk cohorts,” Dr. White says. “Although we screened fewer patients than expected, the results highlight the importance of the ED as a venue for hepatitis C virus testing.”
Despite demonstrating high rates of hepatitis C antibody reactivity among nearly all subgroups tested, the study noted that triage nurses often deviated from the protocol, frequently failed to assess injection drug use risk, and regularly offered screening to patients who were not baby boomers. The discrepancy between the number of accepted screening tests and number of tests actually performed is not unusual, and a variety of factors may be at play. For example, not all patients had blood drawn and some were discharged before venipuncture could take place. Informal discussions with nurses also revealed they often forgot to order the hepatitis C test, citing that they didn’t feel familiar with test ordering or found the process to be inconvenient.
The study also revealed that many patients testing positive for hepatitis C were discharged before having their results disclosed and before confirmatory tests could be conducted. This finding illustrates the importance of increasing the availability of positive test results before discharge and improving laboratory-to-physician communication. These efforts are needed for faster test processing and to improve discharge follow-up protocols.
Dr. White and colleagues also noted that it was difficult to link newly-diagnosed patients to care for hepatitis C. “It takes time to contact patients and arrange follow-up,” he says. “Even with efforts to streamline processes, appointment non-attendance rates were still high, meaning that ongoing outreach and surveillance is required.” The study notes that, in addition, not all patients with reactive hepatitis C tests required immediate referral to a specialist. Referral mechanisms will be site specific and depend on access to care and other resources.
A Worthwhile Effort
Reimbursement for hepatitis C screening presents a significant challenge, according to Dr. White. “Despite this challenge, our findings highlight the significant burden of hepatitis C among patients receiving ED care. EDs can play a critical role in identifying patients with undiagnosed disease, and these are worthwhile efforts considering the growing burden of hepatitis C in the U.S. More resources are needed to support efforts to develop and evaluate policies for ED-based hepatitis C screening and diagnostic testing.” The study group noted that future studies should focus efforts on examining risk- and non-risk-based approaches to hepatitis C screening.
Readings & Resources (click to view)
White DAE, Anderson ES, Pfeil S, Trivedi TK, Alter HJ. Results of a rapid hepatitis C virus screening and diagnostic testing program in an urban emergency department. Ann Emerg Med. 2015 Aug 4 [Epub ahead of print]. Available at: http://www.annemergmed.com/article/S0196-0644(15)00529-6/fulltext.
Galbraith JW, Franco RA, Donnelly JP, et al. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology. 2015;61:776-782.
Galbraith JW, Donnelly JP, Franco RA, et al. National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States. Clin Infect Dis. 2014;59:755-764.
Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61.